Construction of a risk model based on exosome-related genes predict clinical prognosis and therapeutic response and revealing TIMP1 as a promising target in colorectal cancer

Key Points

• The risk model predicts clinical prognosis efficiently in colorectal cancer patients, indicating significant outcomes.
• Key evidence shows an association with specific exosome-related genes revealing potential therapeutic implications.
• The study employs a risk model based on exosome-related gene analysis of colorectal cancer samples for accuracy in prognosis.
• These findings highlight TIMP1 as a promising molecular target for better therapeutic strategies in colorectal cancer, suggesting further investigations.